Suppr超能文献

带 Relay®分支的主动脉覆膜支架的技术要点和临床经验

Technical tips and clinical experience with the Terumo Relay®Branch aortic endovascular graft.

机构信息

Washington University School of Medicine, Section of Vascular Surgery, Department of Surgery, St. Louis, MO, USA -

Washington University School of Medicine, Section of Vascular Surgery, Department of Surgery, St. Louis, MO, USA.

出版信息

J Cardiovasc Surg (Torino). 2023 Feb;64(1):26-32. doi: 10.23736/S0021-9509.22.12552-8.

Abstract

Advances in thoracic endovascular aortic repair (TEVAR) are enabling the treatment of increasingly proximal pathology. While the practice of vascular surgery has thus far been mostly limited to TEVAR in zone 2 or more distally, there are emerging devices for zone 1 and zone 0 repair that do not require any further arch debranching compared with a zone 2 repair. Moreover, such devices set forth repair options for patients unable to tolerate the insult of open surgery. One zone 0 device under evaluation is the Terumo RelayBranch (Terumo, Tokyo, Japan) endovascular graft, which is an off-the-shelf device based on the RelayPro platform (Terumo). This double branch device uniquely features a large gate, facilitating easy cannulation that contains two locking portal stents for the innominate artery (IA) and left common carotid artery (LCCA) branch grafts. Within our institution, we have had excellent technical success with RelayBranch (Terumo) device deployments as part of the Early Feasibility Study, and other centers outside of the USA have published results with this device in small patient series. Notably, there is still a concerning stroke rate associated with the RelayBranch (Terumo) device, with permanent stroke rates higher than expected but similar to those for open repair. Thus, these interventions must be undertaken with careful patient selection, thorough planning, and with the guidance of a proficient endovascular aortic team. In this article, we will outline the necessary preoperative workup, highlight device features, and detail the operative strategy, with tips for technical success. These guidelines from our experience will help facilitate successful utilization of this device when it becomes widely available in practice.

摘要

胸主动脉腔内修复术 (TEVAR) 的进步使治疗近端病变成为可能。尽管血管外科学的实践迄今为止主要局限于第 2 区或更远处的 TEVAR,但目前有一些新兴的第 1 区和第 0 区修复装置,与第 2 区修复相比,不需要进一步的弓分支去分支。此外,这些装置为无法耐受开放手术创伤的患者提供了修复选择。一种正在评估的第 0 区装置是 Terumo RelayBranch(Terumo,东京,日本)血管内移植物,这是一种基于 RelayPro 平台(Terumo)的现成装置。这种双分支装置的独特之处在于有一个大的门,便于容易地进行套管穿刺,其中包含两个用于无名动脉(IA)和左颈总动脉(LCCA)分支移植物的锁定门户支架。在我们的机构中,我们在早期可行性研究中成功地使用 RelayBranch(Terumo)装置进行了部署,并且美国以外的其他中心也在小患者系列中发表了使用该装置的结果。值得注意的是,RelayBranch(Terumo)装置仍然存在较高的卒中率,永久性卒中率高于预期,但与开放修复相似。因此,这些干预措施必须在仔细选择患者、充分计划和在熟练的血管内主动脉团队的指导下进行。在本文中,我们将概述必要的术前检查,突出装置的特点,并详细介绍手术策略,包括技术成功的技巧。这些根据我们的经验制定的指南将有助于在该装置广泛应用于实践时成功使用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验